You just read:

European Commission Approves the Only Immunotherapy for High-risk Neuroblastoma, Bringing Hope to Thousands of Children Affected by a Rare and Devastating Form of Cancer

News provided by

EUSA Pharma (UK) LTD

09 May, 2017, 16:29 BST